- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00921596
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass (CPB) (CPB)
June 14, 2009 updated by: Xijing Hospital
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass, a Single Center's Experience
Conventional cardiac operations are performed with median sternotomy, which is related to great wound, morbidities, longer duration in hospital and most significantly, cosmetic problems.
The investigators invested a new minimally invasive cardiac operation method totally under video-endoscope and peripheral cardiopulmonary bypass.
The investigators' hypothesis is that this new minimally method could provide better cosmetic effects to the patients, and also relate to shorter postoperative hospital stay and better recovery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
800
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xuezeng Xu, MD
- Phone Number: 86-29-84775312
- Email: xuxuez@fmmu.edu.cn
Study Locations
-
-
Shannxi
-
Xi'an, Shannxi, China, 710032
- Recruiting
- Xijing Hospital
-
Principal Investigator:
- Xuezeng Xu, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 70 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- congenital heart defects or heart valve diseases require surgical correction
Exclusion Criteria:
- Body weight < 10kg
- committed with complex congenital heart defect
- anticipated to perform aortic valve repair or replacement
- anticipated to perform aorta repair or replacement
- committed with Femoral vessel diseases unable to perform femoral cannulation
- refuse to perform totally thoracoscope minimally invasive surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Totally endoscopic cardiac operation
Patients with cardiac diseases undergo cardiac operations with totally endoscopic and cardiopulmonary bypass
|
Cardiac operations are performed with three keyholes in the right chest wall.
Video images are obtained by digital thoracoscope through one hole.
Intracardiac lesions are accessed with surgical instruments and repaired through the other two holes.
Cardiopulmonary bypass is set up with femoral cannulations.
Moderate system hypothermic is applied for the operation.
Cardiac arrest is achieved with ascending aorta clamp and cardioplegia solution delivery through aortic root cannulation.
After the intracardiac lesions are repaired, aortic clamp is removed, and the heart is reperfused to restore its spontaneous rhythm.
After the patients are rewarmed to normal temperature, CPB is discontinued.
Femoral cannulations are removed, and surgical wounds are closed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
all cause mortality
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
all cause morbidity
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2000
Primary Completion (ANTICIPATED)
December 1, 2009
Study Completion (ANTICIPATED)
December 1, 2009
Study Registration Dates
First Submitted
June 12, 2009
First Submitted That Met QC Criteria
June 14, 2009
First Posted (ESTIMATE)
June 16, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
June 16, 2009
Last Update Submitted That Met QC Criteria
June 14, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- xinzangwaike0003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
-
UMC UtrechtLeiden University Medical Center; The Interuniversity Cardiology Institute... and other collaboratorsTerminatedMitral Valve Insufficiency | Diseases of Mitral Valve | Heart; Disease, Mitral(Valve)Netherlands
-
Assistance Publique Hopitaux De MarseilleSuspendedAortic Valve Regurgitation AcquiredFrance
-
Edwards LifesciencesRecruitingCardiovascular Diseases | Heart Failure | Heart Valve Diseases | Tricuspid Valve Regurgitation | Tricuspid Valve Insufficiency | Tricuspid Valve DiseaseUnited States, Germany
-
Synecor, LLCUnknownHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Disease
-
Edwards LifesciencesActive, not recruitingHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve DiseaseUnited States, Australia, Brazil
-
Caisson Interventional LLCActive, not recruitingMitral Regurgitation | Valve Disease, Heart | Valve Heart Disease | Mitral Valve Disease | Mitral Valve Failure | Mitral DiseaseUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingAortic Valve Disease | Heart Valve Diseases | Mitral Valve Disease | Tricuspid Valve DiseaseGermany
-
Astana Medical UniversityCompletedMitral Valve Insufficiency | Aortic Valve InsufficiencyKazakhstan
Clinical Trials on cardiac operation with totally endoscopic method
-
Université Libre de BruxellesCompletedCoronary Artery Disease | Heart Failure | Resistance TrainingBelgium
-
Meshalkin Research Institute of Pathology of CirculationCompletedStenosis, Internal Carotid ArteryRussian Federation
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany